A randomized trial for the treatment of refractory status epilepticus

BORIS DOI
Publisher DOI
PubMed ID
20878265
Description
Refractory status epilepticus (RSE) has a mortality of 16-39%; coma induction is advocated for its management, but no comparative study has been performed. We aimed to assess the effectiveness (RSE control, adverse events) of the first course of propofol versus barbiturates in the treatment of RSE.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Rossetti, Andrea O
Milligan, Tracey A
Vulliémoz, Serge
Michaelides, Costas
Lee, Jong Woo
Additional Credits
Series
Neurocritical care
Publisher
Springer
ISSN
1541-6933
Access(Rights)
open.access
Show full item